AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 50 filers reported holding AVROBIO INC in Q1 2023. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $3,000 | +50.0% | 1,979 | -14.9% | 0.00% | – |
Q2 2023 | $2,000 | 0.0% | 2,325 | +24.7% | 0.00% | – |
Q1 2023 | $2,000 | +100.0% | 1,865 | 0.0% | 0.00% | – |
Q4 2022 | $1,000 | 0.0% | 1,865 | -17.4% | 0.00% | – |
Q3 2022 | $1,000 | -50.0% | 2,257 | +15.4% | 0.00% | – |
Q2 2022 | $2,000 | -60.0% | 1,955 | -53.4% | 0.00% | – |
Q1 2022 | $5,000 | -86.1% | 4,192 | -55.6% | 0.00% | – |
Q4 2021 | $36,000 | +12.5% | 9,440 | +61.6% | 0.00% | – |
Q3 2021 | $32,000 | -99.6% | 5,843 | -99.3% | 0.00% | -100.0% |
Q2 2021 | $7,455,000 | +13454.5% | 838,548 | +19519.7% | 0.00% | – |
Q1 2021 | $55,000 | +96.4% | 4,274 | +112.4% | 0.00% | – |
Q4 2020 | $28,000 | +16.7% | 2,012 | +7.9% | 0.00% | – |
Q3 2020 | $24,000 | -29.4% | 1,865 | -2.6% | 0.00% | – |
Q2 2020 | $34,000 | +9.7% | 1,914 | -3.3% | 0.00% | – |
Q1 2020 | $31,000 | +10.7% | 1,979 | +43.3% | 0.00% | – |
Q4 2019 | $28,000 | +2700.0% | 1,381 | +2024.6% | 0.00% | – |
Q4 2018 | $1,000 | -83.3% | 65 | -48.0% | 0.00% | – |
Q3 2018 | $6,000 | – | 125 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Life Science Advisors, LLC | 4,520,863 | $5,968,000 | 0.76% |
Aisling Capital Management LP | 1,009,779 | $1,333,000 | 0.72% |
MPM BioImpact LLC | 647,918 | $855,000 | 0.23% |
GMT CAPITAL CORP | 2,594,914 | $3,425,000 | 0.22% |
New Leaf Venture Partners, L.L.C. | 315,550 | $417,000 | 0.21% |
GSA CAPITAL PARTNERS LLP | 338,422 | $447,000 | 0.06% |
Penn Mutual Asset Management, LLC | 37,306 | $49,000 | 0.06% |
Eversept Partners, LP | 295,369 | $389,887 | 0.03% |
XTX Topco Ltd | 23,289 | $31,000 | 0.01% |
Colonial River Wealth Management, LLC | 17,636 | $23,000 | 0.01% |